Ownership history in Consolidated Portfolio Review Corp Β· 5 quarters on record
This page tracks every 13F SEC filing in which Consolidated Portfolio Review Corp reported a position in ABBOTT LABS (ABT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β sourced directly from SEC EDGAR 13F filings.
π Consolidated Portfolio Review Corp outperformed the S&P 500 by +2.4% annually on this ABT position. Timing score: 25% (1/4 decisions correct). Average cost basis: $120.45. Maximum drawdown during holding period: β1.1%.
β
Outperformed SPY on this position by 2.4% ann.
4 quarters analyzed
β οΈ Poor timing β buys often preceded drops, trims preceded rallies.
1 of 4 add/trim decisions correct
Best entry: $110.45 (2024 Q4) Β· Worst: $134.12 (2025 Q2)
π No drawdown exceeding 20% during the holding period β exceptionally stable.
4 adds Β· 1 trim. Bought during 2 of 2 down-price quarters. π Consistently bullish β fund kept accumulating this position.
βοΈ Portfolio weight has remained relatively stable β conviction maintained.
Currently 0.06% of portfolio
β Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ 4 (annualised). Not investment advice.
As of 2025 Q4 β sorted by position size